D. Fraser Bullock - 10 Jun 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Reporting relationship: Director
Issuer ticker: HCAT
Reported as of: 10 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2021, 16:56:26 UTC
Source filing: View source filing
Reporting owner signature: /s/ Daniel Orenstein, as Attorney-in-Fact

Filing notes and source

Key filing fact

D. Fraser Bullock filed Form 4 for Health Catalyst, Inc. (HCAT) on 14 Jun 2021.

Key facts

This page summarizes D. Fraser Bullock's Form 4 filing for Health Catalyst, Inc. (HCAT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Jun 2021, 16:56.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCAT transaction

Common Stock

Award

Transaction value: $0
Shares: +3,285
Change %: +7.9%
Price: $0.000000
Shares after: 44,999
Date: 10 Jun 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) June 10, 2022 and (ii) the date of the next Annual Meeting of the Issuer's Stockholders.